- Report
- April 2024
- 50 Pages
Global
From €2563EUR$2,650USD£2,196GBP
- Report
- April 2024
- 50 Pages
Global
From €2563EUR$2,650USD£2,196GBP
- Report
- March 2024
- 198 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- July 2023
- 220 Pages
Global
From €1924EUR$1,990USD£1,649GBP
- Report
- April 2024
Global
From €6286EUR$6,500USD£5,387GBP
- Report
- February 2024
- 150 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Report
- February 2024
- 110 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Report
- February 2024
- 150 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Report
- August 2023
- 90 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1209EUR$1,250USD£1,036GBP
- Report
- October 2023
- 177 Pages
Global
From €4739EUR$4,900USD£4,061GBP
- Report
- March 2024
- 200 Pages
Global
From €4013EUR$4,150USD£3,440GBP
- Report
- January 2024
- 200 Pages
Global
From €4013EUR$4,150USD£3,440GBP
- Report
- August 2023
- 145 Pages
Global
From €3046EUR$3,150USD£2,611GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4594EUR$4,750USD£3,937GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4594EUR$4,750USD£3,937GBP
- Report
- February 2024
- 80 Pages
Europe
From €4594EUR$4,750USD£3,937GBP
- Report
- February 2024
- 70 Pages
United States
From €4594EUR$4,750USD£3,937GBP
Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more